课题基金 / 基金详情

项目摘要

项目成果

Kavita Madhav Dhodapkar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dendritic cells (DCs) are specialized antigen presenting cells that can mediate both T cell immunity as well as immune tolerance. The nature of specific maturation signal delivered to DCs is an important determinant of DC function. Fc? receptor (Fc?R) system includes activating as well as inhibitory receptors that are usually co-expressed on the cell surface. The balance between the activating and inhibitory signals determines the outcome of immune complex mediated inflammation and immunity. We have recently shown that selective blockade of the inhibitory Fc?R, Fc?RIIB on DCs leads to DC activation and enhanced generation of T cell immunity. This DC maturation is distinct and characterized by induction of several chemokines and cytokines as well as type I interferon (IFN) response genes. Our preliminary data suggests that Fc?R matured DCs have the ability to activate IL17 producing CD4 as well as CD8 T cells in humans. Our hypothesis is that the balance of Fc?R signaling impacts induction of Th17 cells by DCs. The aims of this application are I) To compare the properties of human IL17 producing T cells induced by Fc?R activated DCs with those generated by DCs matured with inflammatory cytokines zymosan or peptidoglycan. 2) To evaluate the role of activating Fc?Rs and downstream molecules in DC mediated activation of Th17-1 cells 3) To evaluate the anti-tumor function of the Th17-1 cells induced by DCs loaded with opsonized apoptotic tumor cells. These studies will help us understand the role Fc? receptors on dendritic cell biology and provide novel insights into Fc?R mediated immune regulation in inflammation and disease as well as tumor immunity. . PUBLIC HEALTH RELEVANCE: Dendritic cells (DCs) are specialized antigen presenting cells that mediate activation of T cells. We have previously shown that the function of DCs can be modulated by altering the signaling via their Fc? receptors. In this application we will examine the effect of the modulation of the Fc? receptor balance on the ability of DCs to induce Th17 cells, the pathways involved in the induction of Th17 cells as well as the function of the Th17 cells induced by the DCs.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s11060-017-2515-8
发表时间: 2017-08
期刊: Journal of neuro-oncology
影响因子: 3.9
作者: [Vasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM]
通讯作者: Dhodapkar KM
Core 2
  • 批准号:
    10411670
  • 项目类别:
  • 资助金额:
    $42.64万
  • 财政年份:
    2022
  • 负责人:
    Kavita Madhav Dhodapkar
  • 依托单位:
Core 2
  • 批准号:
    10631163
  • 项目类别:
  • 资助金额:
    $37.36万
  • 财政年份:
    2022
  • 负责人:
    Kavita Madhav Dhodapkar
  • 依托单位:
B cell depletion to prevent autoimmunity
  • 批准号:
    10439680
  • 项目类别:
  • 资助金额:
    $39.71万
  • 财政年份:
    2020
  • 负责人:
    Kavita Madhav Dhodapkar
  • 依托单位:
B cell depletion to prevent autoimmunity
  • 批准号:
    10665681
  • 项目类别:
  • 资助金额:
    $39.4万
  • 财政年份:
    2020
  • 负责人:
    Kavita Madhav Dhodapkar
  • 依托单位:
海外基金